Testimonies from the Trenches Series - Low-Barrier Buprenorphine Treatment (On-Demand)
Recorded On: 12/09/2021
Testimonies from the Trenches: Innovations in Clinical Practice -
Low-Barrier Buprenorphine Treatment.
This is a short didactic presentation. This lecture will orient the audience to the tenants of low-barrier opioid use disorder treatment with buprenorphine. It will prepare learners to integrate this care into their practices.
This webinar is free to AOAAM members.
Non-members at $25. Consider membership!
- Introduce low-barrier buprenorphine treatment approaches
- Identify common barriers to receipt of OUD care with buprenporphine and review strategies to make care more accessible, including alternative induction approaches
- Increase comfort with providing OUD treatment to patients who have previously struggled to access care in traditional SUD treatment settings
- This activity is designed to increase comfort and competence in offering low-barrier buprenorphine treatment and to treating patients who have struggled to engage in traditional OUD treatment programs. Participants will integrate low-barrier treatment approaches into their care and will be able to better serve patients with OUD.
CME: This webinar series has been approved for a maximum 4, AOA Category 1-A CME credits, and AOA designates this for a maximum of 4, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.
Shoshana Aronowitz, PhD, MSHP, FNP-BC
Shoshana Aronowitz is a family nurse practitioner, community-engaged health services researcher, and assistant professor in the Department of Family and Community Health at the University of Pennsylvania School of Nursing. Her research examines innovative delivery models to promote equitable access to substance use treatment and harm reduction services, as well as racial disparities in pain management in the context of the opioid overdose crisis. She received her bachelor?s degree from McGill University, her master?s in nursing from the University of Vermont, her PhD from the University of Pennsylvania School of Nursing, her master?s in health policy from the University of Pennsylvania School of Medicine, and completed her postdoctoral fellowship at the National Clinician Scholars Program University of Pennsylvania site. She provides substance use disorder treatment at Prevention Point Philadelphia and Ophelia Health. In addition, she is a member of SOL Collective, a grassroots harm reduction organization located in Philadelphia.